Inhibition of lung cancer growth: ATP citrate lyase knockdown and statin treatment leads to dual blockade of mitogen-activated protein Kinase (MAPK) and Phosphatidylinositol-3-kinase (PI3K)/AKT pathways
出版年份 2011 全文链接
标题
Inhibition of lung cancer growth: ATP citrate lyase knockdown and statin treatment leads to dual blockade of mitogen-activated protein Kinase (MAPK) and Phosphatidylinositol-3-kinase (PI3K)/AKT pathways
作者
关键词
-
出版物
JOURNAL OF CELLULAR PHYSIOLOGY
Volume 227, Issue 4, Pages 1709-1720
出版商
Wiley
发表日期
2011-06-18
DOI
10.1002/jcp.22895
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Statins inhibit Akt/PKB signaling via P2X7 receptor in pancreatic cancer cells
- (2009) Oras Mistafa et al. BIOCHEMICAL PHARMACOLOGY
- Basal Subtype and MAPK/ERK Kinase (MEK)-Phosphoinositide 3-Kinase Feedback Signaling Determine Susceptibility of Breast Cancer Cells to MEK Inhibition
- (2009) O. K. Mirzoeva et al. CANCER RESEARCH
- Tamoxifen inhibits tumor cell invasion and metastasis in mouse melanoma through suppression of PKC/MEK/ERK and PKC/PI3K/Akt pathways
- (2009) Hiroshi Matsuoka et al. EXPERIMENTAL CELL RESEARCH
- Simultaneous inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways augment the sensitivity to actinomycin D in Ewing sarcoma
- (2009) Takatoshi Yamamoto et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- ATP-Citrate Lyase Links Cellular Metabolism to Histone Acetylation
- (2009) K. E. Wellen et al. SCIENCE
- ATP Citrate Lyase: Activation and Therapeutic Implications in Non-Small Cell Lung Cancer
- (2008) T. Migita et al. CANCER RESEARCH
- The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
- (2008) Ralph J. DeBerardinis et al. Cell Metabolism
- Cotargeting survival signaling pathways in cancer
- (2008) Steven Grant JOURNAL OF CLINICAL INVESTIGATION
- Statin-Induced Inhibition of 3-Hydroxy-3-Methyl Glutaryl Coenzyme A Reductase Sensitizes Human Osteosarcoma Cells to Anticancer Drugs
- (2008) O. Fromigue et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Epithelial to mesenchymal transition derived from repeated exposure to gefitinib determines the sensitivity to EGFR inhibitors in A549, a non-small cell lung cancer cell line
- (2008) Jin Kyung Rho et al. LUNG CANCER
- Pyruvate kinase M2 is a phosphotyrosine-binding protein
- (2008) Heather R. Christofk et al. NATURE
- Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers
- (2008) Jeffrey A Engelman et al. NATURE MEDICINE
- PI3K/Akt: getting it right matters
- (2008) T F Franke ONCOGENE
- PI3K pathway alterations in cancer: variations on a theme
- (2008) T L Yuan et al. ONCOGENE
- Reversal of chemoresistance and enhancement of apoptosis by statins through down-regulation of the NF-κB pathway
- (2007) Kwang Seok Ahn et al. BIOCHEMICAL PHARMACOLOGY
- Specific inhibition of basal mitogen-activated protein kinases and phosphatidylinositol 3 kinase activities in leukemia cells: a possible therapeutic role for the kinase inhibitors
- (2007) Pierre Champelovier et al. EXPERIMENTAL HEMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started